Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Store lyophilized MOTS-C in the freezer and reconstituted MOTS-C in the refrigerator
Unopened vs
EGFR-induced and PKC monoubiquitylation-dependent NF-B activation upregulates PKM2 expression and promotes tumorigenesis
Avoid direct contact with eyes
Adding cagrilintide to tirzepatide Theoretical protocol (not clinically studied): If on tirzepatide 10-15mg: Stable on tirzepatide for 4+ weeks Continue tirzepatide at current dose Add cagrilintide 0.6mg weekly Standard cagrilintide titration to 2.4mg Rationale: Tirzepatide is dual GIP/GLP-1 (very powerful alone) Adding amylin pathway could theoretically enhance No clinical data on this combination Uncertain if additional benefit over tirzepatide alone Concerns: GI side effects may be severe (both slow gastric emptying) Tirzepatide already produces 15-22% weight loss alone Unclear if cagrilintide adds meaningful benefit Expensive combination Verdict: Wait for clinical data
10 mg vial reconstitution math BAC water added 1.0 mL Final concentration 10 mg/mL Research amount 1 mg Draw volume 0.10 mL U-100 syringe units 10 units BAC water added 1.0 mL Final concentration 10 mg/mL Research amount 2.5 mg Draw volume 0.25 mL U-100 syringe units 25 units BAC water added 1.0 mL Final concentration 10 mg/mL Research amount 5 mg Draw volume 0.50 mL U-100 syringe units 50 units A 5 mg amount uses half of this vial and requires a 0.50 mL draw at this concentration
.jpg)